Medlander Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
550
- Stock Symbol
-
688273
- Investments
-
4
- Share Price
-
$3.88
- (As of Friday Closing)
Medlander General Information
Description
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales, and service of related products in the field of pelvic floor and postpartum rehabilitation. Its products mainly include: biostimulation feedback instrument, color ultrasound diagnosis and evaluation system, magnetic stimulator, high-frequency evaluation electrocautery instrument, pelvic floor training instrument, portable postpartum recovery instrument, home pelvic floor rehabilitation therapy instrument, etc., which are widely used in obstetrics and gynecology, pelvic floor rehabilitation center, urology, anorectal department and other hospital departments.
Contact Information
Website
www.medlander.comCorporate Office
- Building 5, Acceleration Zone Nanjing Life Science and Technology Innovation Park
- Number 6 Qiande Road, 211100 Jiangning District
- Nanjing, Jiangsu 211100
- China
Corporate Office
- Building 5, Acceleration Zone Nanjing Life Science and Technology Innovation Park
- Number 6 Qiande Road, 211100 Jiangning District
- Nanjing, Jiangsu 211100
- China
Medlander Stock Performance
As of 13-Nov-2026, Medlander’s stock price is $3.88. Its current market cap is $388M with 100M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.88 | $3.97 | $3.63 - $8.76 | $388M | 100M | 1.12M | $0.09 |
Medlander Financials Summary
As of 30-Sep-2026, Medlander has a trailing 12-month revenue of $55.5M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 340,698 | 499,666 | 201,353 | 320,862 |
| Revenue | 55,533 | 60,016 | 59,167 | 48,174 |
| EBITDA | 8,518 | 18,812 | 20,022 | 14,818 |
| Net Income | 9,243 | 14,271 | 14,157 | 12,695 |
| Total Assets | 233,420 | 232,862 | 211,863 | 216,393 |
| Total Debt | 3,247 | 4,797 | 2,124 | 1,200 |
Medlander Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medlander Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Medlander Patents
Medlander Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3342453-B1 | Smart pelvic floor muscle rehabilitation training device | Active | 28-Aug-2015 | ||
| EP-3342453-A1 | Smart pelvic floor muscle rehabilitation training device and method for using the same | Active | 28-Aug-2015 | ||
| EP-3342453-A4 | Smart pelvic floor muscle rehabilitation training device and method for using the same | Active | 28-Aug-2015 | ||
| WO-2017035951-A1 | Smart pelvic floor muscle rehabilitation training device and method for using the same | Inactive | 28-Aug-2015 | A61N1/36007 |
Medlander Signals
Medlander Investments & Acquisitions (4)
Medlander’s most recent deal was a Later Stage VC with Gimay for . The deal was made on 04-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Gimay | 04-Jun-2026 | Later Stage VC | Electronics (B2C) | ||
| Zhimei Xingchen | 03-Jun-2026 | Early Stage VC | Therapeutic Devices | ||
| Wrightin | 24-May-2024 | Merger/Acquisition | Therapeutic Devices | ||
| Xiaofu Tech | 26-Jan-2024 | Merger/Acquisition | Electronics (B2C) |
Medlander ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Medlander Exits (1)
Medlander’s most recent exit was on 26-Jan-2024 from Xiaofu Tech. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Xiaofu Tech | 26-Jan-2024 | Completed |
|
Medlander Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Wrightin | Nanjing, China | 2017 |
Medlander FAQs
-
When was Medlander founded?
Medlander was founded in 2013.
-
Where is Medlander headquartered?
Medlander is headquartered in Nanjing, China.
-
What is the size of Medlander?
Medlander has 550 total employees.
-
What industry is Medlander in?
Medlander’s primary industry is Diagnostic Equipment.
-
Is Medlander a private or public company?
Medlander is a Public company.
-
What is Medlander’s stock symbol?
The ticker symbol for Medlander is 688273.
-
What is the current stock price of Medlander?
As of 13-Nov-2026 the stock price of Medlander is $3.88.
-
What is the current market cap of Medlander?
The current market capitalization of Medlander is $388M.
-
What is Medlander’s current revenue?
The trailing twelve month revenue for Medlander is $55.5M.
-
What is Medlander’s annual earnings per share (EPS)?
Medlander’s EPS for 12 months was $0.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process